Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk

October 31, 2018 Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma

The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …
News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018 Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …
News
slimming-2728331_960_720

Effective preventative therapies for type 2 diabetes are underused, new research argues

October 30, 2018 Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes

New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
News
shutterstock_243110086

Not so crystal clear: The EU’s clinical reporting problem

October 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …
Feature

US court overturns J&J’s Zytiga patent in combination with prednisone

October 29, 2018 Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone

A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …
News

Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

October 29, 2018 Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma

Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …
News

Vaccine coverage falls by 6.2% since last year

October 29, 2018 Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines

Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …
News
shutterstock_273326141

Pfizer and Novartis partner up to develop combo therapies for NASH

October 29, 2018 Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …
News

HHS Secretary Alex Azar responds to pharma sector’s criticism over Medicare pricing plan

October 29, 2018 Sales and Marketing

US Health and Human Services (HHS) Secretary Alex Azar responded to industry criticism on Friday after big pharma warned that …
News
donald_trump_8567813820_2

President Trump unveils new plans to bring US drug prices in line with the rest of the world

October 26, 2018 Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

October 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
News

NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia

October 26, 2018 Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax

It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …
News
amgen_hq

Amgen slashes price of cholesterol drug Repatha by 60%

October 25, 2018 Sales and Marketing Repatha, cholestrol, drug, medicine, pricing

American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …
News

FDA generics approvals up 90% compared to 2014

October 25, 2018 Sales and Marketing FDA, Trump, generics, pharma

Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …
News
flu

First novel, single-dose flu drug approved in US in almost 20 years

October 25, 2018 Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma

The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025